Skip to main content

Genentech Leases Life Sciences Building at Gateway Commons

Published 12/20/2021

Genentech has agreed to a whole-building lease for a 229,000-sf life sciences facility at Gateway Commons in South San Francisco. Developed by Alexandria Real Estate Equities and Boston Properties, 751 Gateway will provide leading-edge lab and office environments for biomedical and pharmaceutical research. Featuring best-in-class amenities, the collaborative structure represents the first phase of a vibrant biomedical campus. Construction is ongoing with initial occupancy expected in early 2024. 

Genentech is subsidiary of Roche, a global pharmaceutical company based in Basel, Switzerland.